133 related articles for article (PubMed ID: 15531235)
1. Nonobese diabetic mice have diminished gallbladder motility and shortened crystal observation time.
Graewin SJ; Kiely JM; Lee KH; Svatek CL; Nakeeb A; Pitt HA
J Gastrointest Surg; 2004 Nov; 8(7):824-9; discussion 829-30. PubMed ID: 15531235
[TBL] [Abstract][Full Text] [Related]
2. Ciliary neurotrophic factor restores gallbladder contractility in leptin-resistant obese diabetic mice.
Graewin SJ; Kiely JM; Svatek CL; Pitt HA
J Surg Res; 2006 Jan; 130(1):146-51. PubMed ID: 16389100
[TBL] [Abstract][Full Text] [Related]
3. Leptin-resistant obese mice have paradoxically low biliary cholesterol saturation.
Tran KQ; Graewin SJ; Swartz-Basile DA; Nakeeb A; Svatek CL; Pitt HA
Surgery; 2003 Aug; 134(2):372-7. PubMed ID: 12947343
[TBL] [Abstract][Full Text] [Related]
4. Leptin-resistant obese mice do not form biliary crystals on a high cholesterol diet.
Graewin SJ; Lee KH; Tran KQ; Goldblatt MI; Svatek CL; Nakeeb A; Pitt HA
J Surg Res; 2004 Dec; 122(2):145-9. PubMed ID: 15555610
[TBL] [Abstract][Full Text] [Related]
5. High dietary carbohydrates decrease gallbladder volume and enhance cholesterol crystal formation.
Mathur A; Megan M; Al-Azzawi HH; Lu D; Swartz-Basile DA; Nakeeb A; Pitt HA
Surgery; 2007 May; 141(5):654-9. PubMed ID: 17462466
[TBL] [Abstract][Full Text] [Related]
6. Gallbladder motility in agouti-yellow and leptin-resistant obese mice.
Tran KQ; Swartz-Basile DA; Nakeeb A; Pitt HA
J Surg Res; 2003 Jul; 113(1):56-61. PubMed ID: 12943811
[TBL] [Abstract][Full Text] [Related]
7. The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.
Wang HH; Portincasa P; Wang DQ
Eur J Clin Invest; 2016 Feb; 46(2):158-69. PubMed ID: 26683129
[TBL] [Abstract][Full Text] [Related]
8. Diminished gallbladder motility in Rotund leptin-resistant obese mice.
Graewin SJ; Tran KQ; Naggert JK; Lee KH; Swartz-Basile D; Nakeeb A; Pitt HA
HPB (Oxford); 2005; 7(2):139-43. PubMed ID: 18333178
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic Fatty gallbladder disease: the influence of diet in lean and obese mice.
Goldblatt MI; Swartz-Basile DA; Al-Azzawi HH; Tran KQ; Nakeeb A; Pitt HA
J Gastrointest Surg; 2006 Feb; 10(2):193-201. PubMed ID: 16455450
[TBL] [Abstract][Full Text] [Related]
10. Lack of endogenous cholecystokinin promotes cholelithogenesis in mice.
Wang HH; Liu M; Portincasa P; Tso P; Wang DQ
Neurogastroenterol Motil; 2016 Mar; 28(3):364-75. PubMed ID: 26604077
[TBL] [Abstract][Full Text] [Related]
11. Diabetes and hyperlipidemia correlate with gallbladder contractility in leptin-related murine obesity.
Tran KQ; Goldblatt MI; Swartz-Basile DA; Svatek C; Nakeeb A; Pitt HA
J Gastrointest Surg; 2003 Nov; 7(7):857-62; discussion 863. PubMed ID: 14592658
[TBL] [Abstract][Full Text] [Related]
12. Gallbladder myocytes are short and cholecystokinin-resistant in obese diabetic mice.
Graewin SJ; Lee KH; Kiely JM; Svatek CL; Nakeeb A; Pitt HA
Surgery; 2004 Aug; 136(2):431-6. PubMed ID: 15300211
[TBL] [Abstract][Full Text] [Related]
13. Decreased gallbladder response in leptin-deficient obese mice.
Goldblatt MI; Swartz-Basile DA; Svatek CL; Nakeeb A; Pitt HA
J Gastrointest Surg; 2002; 6(3):438-42; discussion 443-4. PubMed ID: 12022998
[TBL] [Abstract][Full Text] [Related]
14. Small gallstones, preserved gallbladder motility, and fast crystallization are associated with pancreatitis.
Venneman NG; Renooij W; Rehfeld JF; VanBerge-Henegouwen GP; Go PM; Broeders IA; van Erpecum KJ
Hepatology; 2005 Apr; 41(4):738-46. PubMed ID: 15793851
[TBL] [Abstract][Full Text] [Related]
15. Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient mice.
Wang HH; Portincasa P; Liu M; Tso P; Samuelson LC; Wang DQ
Biochim Biophys Acta; 2010 Feb; 1801(2):138-46. PubMed ID: 19836465
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone increases gallbladder volume in insulin-resistant obese mice.
Al-Azzawi HH; Mathur A; Lu D; Swartz-Basile DA; Nakeeb A; Pitt HA
J Surg Res; 2006 Dec; 136(2):192-7. PubMed ID: 17045610
[TBL] [Abstract][Full Text] [Related]
17. An Update on the Lithogenic Mechanisms of Cholecystokinin a Receptor (CCKAR), an Important Gallstone Gene for
Wang HH; Portincasa P; Liu M; Tso P; Wang DQ
Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33260332
[TBL] [Abstract][Full Text] [Related]
18. Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones.
Wang HH; Portincasa P; Wang DQ
Curr Med Chem; 2019; 26(19):3407-3423. PubMed ID: 28625150
[TBL] [Abstract][Full Text] [Related]
19. Leptin regulates gallbladder genes related to gallstone pathogenesis in leptin-deficient mice.
Graewin SJ; Kiely JM; Lu D; Svatek CL; Al-Azzawi HH; Swartz-Basile DA; Pitt HA
J Am Coll Surg; 2008 Mar; 206(3):503-10. PubMed ID: 18308222
[TBL] [Abstract][Full Text] [Related]
20. Effect of the prokinetic agent, erythromycin, in the Richardson ground squirrel model of cholesterol gallstone disease.
Xu QW; Scott RB; Tan DT; Shaffer EA
Hepatology; 1998 Sep; 28(3):613-9. PubMed ID: 9731548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
